These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Malignant melanoma: hidden behind a black veil. Winters K N Z Med J; 2008 Oct; 121(1283):105-7. PubMed ID: 18841192 [No Abstract] [Full Text] [Related]
65. A phase II trial of isolated limb infusion with melphalan and dactinomycin for regional melanoma and soft tissue sarcoma of the extremity. Brady MS; Brown K; Patel A; Fisher C; Marx W Ann Surg Oncol; 2006 Aug; 13(8):1123-9. PubMed ID: 16791448 [TBL] [Abstract][Full Text] [Related]
66. The role of perfusion therapy in malignant melanoma. Key JA Can Med Assoc J; 1968 Jul; 99(1):11-6. PubMed ID: 5662998 [No Abstract] [Full Text] [Related]
68. Double isolated limb infusion with cytotoxic agents for recurrent and metastatic limb melanoma. Lindnér P; Thompson JF; De Wilt JH; Colman M; Kam PC Eur J Surg Oncol; 2004 May; 30(4):433-9. PubMed ID: 15063898 [TBL] [Abstract][Full Text] [Related]
69. Treatment options for brain metastases from melanoma. McWilliams RR; Rao RD; Brown PD; Link MJ; Buckner JC Expert Rev Anticancer Ther; 2005 Oct; 5(5):809-20. PubMed ID: 16221051 [TBL] [Abstract][Full Text] [Related]
70. [Ethical limits of the current treatment of melanoma]. Bonérandi JJ Ann Dermatol Venereol; 1993; 120(6-7):435-6. PubMed ID: 8279786 [No Abstract] [Full Text] [Related]
71. Management of local or regional non-nodal disease. Racz JM; Block MS; Baum CL; Jakub JW J Surg Oncol; 2019 Jan; 119(2):187-199. PubMed ID: 30548554 [TBL] [Abstract][Full Text] [Related]
72. [Radiotherapy with intra-arterial chemotherapy. Treatment with 5-(3,3 dimethyl-1-triazeno)imidazole-4-carboxamide. Effect in malignant melanoma of the extremities]. Gundersen S; Hager B; Tausjø J Tidsskr Nor Laegeforen; 1985 Aug; 105(24):1617-9. PubMed ID: 4060116 [No Abstract] [Full Text] [Related]
73. Management of in-transit metastases from cutaneous malignant melanoma. Hayes AJ; Clark MA; Harries M; Thomas JM Br J Surg; 2004 Jun; 91(6):673-82. PubMed ID: 15164434 [TBL] [Abstract][Full Text] [Related]
74. [Comment on the contribution by F. Ehring: Regression of over 150 skin metastases of malignant melanoma by homeopathic complex therapy]. Grond K Hautarzt; 1989 Jul; 40(7):464. PubMed ID: 2759865 [No Abstract] [Full Text] [Related]
75. Functional morbidity after regional isolated perfusion of the limb for melanoma. van Geel AN; van Wijk J; Wieberdink J Cancer; 1989 Mar; 63(6):1092-6. PubMed ID: 2917313 [TBL] [Abstract][Full Text] [Related]
76. Therapy for unresectable recurrent and in-transit extremity melanoma. Gimbel MI; Delman KA; Zager JS Cancer Control; 2008 Jul; 15(3):225-32. PubMed ID: 18596674 [TBL] [Abstract][Full Text] [Related]
77. Laser ablation and cryotherapy of melanoma metastases. John HE; Mahaffey PJ J Surg Oncol; 2014 Mar; 109(4):296-300. PubMed ID: 24249157 [TBL] [Abstract][Full Text] [Related]
78. Regional perfusion for melanoma: was it worth the bother? Cox KR; Ewing M Br J Surg; 1969 Aug; 56(8):615. PubMed ID: 5797732 [No Abstract] [Full Text] [Related]
79. Complete remission seven years after treatment for metastatic malignant melanoma. Petit T; Janser JC; Petit JC Cancer; 1996 Aug; 78(3):571. PubMed ID: 8697410 [No Abstract] [Full Text] [Related]
80. The Contemporary Role of Major Amputation in the Management of Advanced Limb Melanoma. Read RL; Stalley P; Thompson JF Ann Surg Oncol; 2015 Nov; 22(12):4067-72. PubMed ID: 25712799 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]